RNS Number:2049T
ReGen Therapeutics PLC
12 December 2003


ReGen Therapeutics Plc

12 December 2003



SUBSTANTIAL SHAREHOLDING

ReGen Therapeutics Plc (the "Company") announces that on 12 December 2003 it
received notification from Mr P. Garrod that he is beneficially interested in
27,500,000 ordinary shares of the Company representing 10.7% of the current
issued share capital of the Company.


For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEAAAAFALDFFE